Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05836688 · ClinicalTrials.gov registry record · NA
A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors
A NA study of Testicular Cancer, sponsored by University of California, Irvine.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 1
- Study location
NCT05836688 is a NA study of Testicular Cancer that is actively recruiting participants, run by University of California, Irvine. The registered enrollment target is 250 participants, above the 72-participant average among 11 other Testicular Cancer trials with a reported enrollment target (247% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05836688, a NA study of Testicular Cancer, is actively recruiting participants, sponsored by University of California, Irvine.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a randomized controlled biobehavioral efficacy trial designed to investigate the feasibility and acceptability of a novel intervention, Goal-focused Emotion-Regulation Therapy (GET) aimed at improving distress symptoms, emotion regulation, goal navigation skills, and stress-sensitive biomarkers in young adult testicular cancer patients. Participants will be randomized to receive six sessions of GET or Individual Supportive Listening (ISL) delivered over eight weeks. In addition to indicators of intervention feasibility, the investigators will measure primary (depressive and anxiety symptoms) and secondary (emotion regulation and goal navigation skills, career confusion) psychological outcomes prior to (T0), immediately after (T1), twelve weeks after intervention (T2) and 24 weeks after the intervention (T3). Additionally, identified biomarkers will be measured at baseline and at T1, T2, and T3.
Conditions Studied
Interventions
- BEHAVIORAL Goal-Focused Emotion-Regulation Therapy (GET)
- BEHAVIORAL Individual Supportive Listening
Study Locations (1)
California
- University of California, Irvine - Irvine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2023-11-01 |
| Est. Completion | 2028-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05836688
The ClinicalTrials.gov registry entry for NCT05836688 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 72-participant average among 11 other Testicular Cancer trials with a reported enrollment target (247% higher). The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Testicular Cancer appearing as the primary indexed condition, and to 2 interventions - of which Goal-Focused Emotion-Regulation Therapy (GET) is the first listed.
NCT05836688 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05836688 about?
NCT05836688 is a clinical study titled "A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors". This study is a randomized controlled biobehavioral efficacy trial designed to investigate the feasibility and acceptability of a novel intervention, Goal-focused Emotion-Regulation Therapy (GET) aimed at improving distress symptoms, emotion regulation, goal navigation skills, and stress-sensitive b...
What is the current status of trial NCT05836688?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2023-11-01. Estimated completion is 2028-07.
What conditions does trial NCT05836688 study?
This clinical trial studies the following conditions: Testicular Cancer.
What interventions are being tested in trial NCT05836688?
The interventions under investigation include: Goal-Focused Emotion-Regulation Therapy (GET) (BEHAVIORAL), Individual Supportive Listening (BEHAVIORAL).
Who is sponsoring clinical trial NCT05836688?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05836688 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Testicular Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Patient Reported Experiences With Sparing External Oblique Fascia Vs Standard Inguinal Orchiectomy
RECRUITING · NA
-
A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest
RECRUITING · NA
-
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
RECRUITING · NA
-
Pursuing Exploration Into the Supportive Care Needs and Intervention Preferences of Survivors of Testicular Cancer
ACTIVE NOT RECRUITING · NA
-
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
RECRUITING · Phase 1
-
Intrathecal Morphine Versus Intravenous Methadone for Postoperative Analgesia Following Retroperitoneal Lymph Node Dissection.
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.